InteKrin Therapeutics Announces Appointment of Geoffrey M. Parker as Chief Business Officer

... of the InteKrin team as we complete our Phase 2 work and plan to advance into Phase 3." About INT131 INT131 is a next-generation insulin sensitizer currently in Phase 2b testing that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes....

InteKrin Therapeutics Announces INT131 Phase 2a Results at the 2009 American Diabetes Association Annual Meeting

...a. "The key observation from this study is that INT131 is a potent insulin sensitizer that lowers fasting glucose as well as the maximal dose of the TZDs while m...rch, 2009. About INT131 INT131 is a next-generation, non-TZD insulin sensitizer and selective modulator of PPARgamma (SPPARM). INT131 belongs to a unique,...

India's Share in Global Diabetes Research is One Percent

...d too badly. For instance, Dr Reddy's Laboratory, Hyderabad is in the third phase of clinical trials of a new class of anti-diabetic drugs, an insulin sensitizer for type-2 diabetes. The Bangalore-based Biocon, after introducing Insugen -- the first human recombinant insulin in India -- has an intra-na...

Sensitizer in Medical Technology

Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment

Poster Presented at the 2008 AACR Annual Meeting SOMERSET, N.J., April 14 /PRNewswire-FirstCall/ -- Alfacell Corporation (Nasdaq: ACEL ) today announced that Dr. Intae Lee with the University of Pennsylvania has reported that Alfacell's ONCONASE (ranpirnase) could be a promising r...

InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting

...lucose Without Typical Thiazolidinedione (TZD) Side Effects in Patients with Type 2 Diabetes." About INT131 INT131 is a next-generation insulin sensitizer currently in Phase 2b testing that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes....

InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131

...on of Type 2 Diabetes, and it remains inadequately addressed by current therapies. INT131 has been demonstrated to be a potent and efficacious insulin sensitizer in humans and offers the opportunity for disease modification without the edema and weight gain of current TZD therapies," said Alex DePaoli, MD, Inte...

Takeda Submits New Drug Application for Alogliptin (SYR-322) in the U.S.

...s by developing innovative pharmaceutical solutions to help manage their condition. In 1999, Takeda launched ACTOS(R) (pioglitazone HCl) -- an insulin sensitizer which today is available globally -- followed in recent years by the introduction of the ACTOS family of products, with more than 75 million prescript...

Allos Therapeutics' PDX Granted Orphan Medicinal Product Designation by the European Commission

...rapeutics for the treatment of cancer. The Company has two product candidates in late-stage clinical development: EFAPROXYN (efaproxiral), a radiation sensitizer currently under evaluation in a pivotal Phase 3 trial in women with brain metastases originating from breast cancer, and PDX (pralatrexate), a novel a...

Sensitizer in Biological Technology

Mindset BioPharmaceuticals (USA) Inc Obtains Notice of Allowance for European Patent Related to Use of Insulin Sensitizers in Senile Dementia, Dementia and Memory Loss

... patent applications describing the use of insulin sensitizer drugs for the prevention and treatment of memory l... from resistance to the action of insulin. Insulin sensitizer drugs such as Rosiglitazone and Pioglitazone help ...ral clinical studies have shown that these insulin sensitizer drugs improve learning and memory. Dr. Daniel...

InteKrin Therapeutics to Present at the 27th Annual JP Morgan Healthcare Conference on Tuesday, January 13

...ected for its ability to separate powerful PPAR anti-diabetic efficacy from these serious TZD side effects. INT131 is a next-generation insulin sensitizer that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. Treating and improving insuli...

Sensitizer in Biological Products

Dodeca Silver Stain Kit, large from Bio-Rad

Description:...ainers. This silver stain kit can detect nanogram quantities of proteins in polyacrylamide gels and are mass spectrometry compatible. The kit includes sensitizer concentrate, silver reagent concentrate, background reducer concentrate, image developer concentrate, and development buffer concentrate. Sufficient r...
Company:Bio-Rad